| Efficacy Study of IgY (Antibody Against Pseudomonas) in Cystic Fibrosis Patients (NCT01455675) | Mukoviszidose Institut gGmbH | 2011-10-01 |
| Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients? (NCT01002534) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2011-10-01 |
| Early Intervention in Cystic Fibrosis Exacerbation (NCT01104402) | Johns Hopkins University | 2011-10-01 |
| Prevention of CF Exacerbation in Childhood: PREVEC Study (NCT01241890) | Maastricht University Medical Center | 2011-10-01 |
| Eficacy of Long-term Suplementation With Docosahexaenoic Acid in Patients With Cystic Fibrosis (NCT01783613) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2011-10-01 |
| Imaging Airway Liquid Absorption in Cystic Fibrosis (NCT01486199) | University of Pittsburgh | 2011-10-01 |
| Pharmacokinetic Study of Aerosolized Colimycin in Cystic Fibrosis (NCT01537614) | Poitiers University Hospital | 2011-10-01 |
| Combined Inspiratory Muscle and 'Whole Muscle' Training in Children With Cystic Fibrosis (NCT01706445) | Universidad Europea de Madrid | 2011-09-01 |
| Effects of a Comprehensive Patient-centered Health Service in Cystic Fibrosis (VEMSE-CF) (NCT03423576) | Mukoviszidose Institut gGmbH | 2011-08-01 |
| Registry to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Cystic Fibrosis Patients (NCT01375036) | Gilead Sciences | 2011-08-01 |
| Cystic Fibrosis and Endothelial Function: At Rest and During Exercise (NCT01772758) | Augusta University | 2011-08-01 |
| Aztreonam Lysine for Pseudomonas Infection Eradication Study (NCT01375049) | Gilead Sciences | 2011-08-01 |
| Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis (NCT01427712) | Mylan Inc. | 2011-08-01 |
| Chest Wall Motion Analysis in Disease (NCT02958683) | Heart of England NHS Trust | 2011-07-01 |
| Costimulatory Molecules as Biomarkers in Cystic Fibrosis (NCT01353950) | Oregon Health and Science University | 2011-07-01 |
| Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis (NCT01755455) | Dartmouth-Hitchcock Medical Center | 2011-06-01 |
| Bronchial Inflammation of Small Airways in Patients With Cystic Fibrosis (NCT01479166) | Johann Wolfgang Goethe University Hospital | 2011-06-01 |
| Induction of Neutrophilic Traps ( NETs ) by the Environment and Infectious Inflammatory Lung Cystic Fibrosis (NCT02564393) | University Hospital, Tours | 2011-05-01 |
| RATNO, Reducing Antibiotic Tolerance Using Nitric Oxide in CF - a Phase 2 Pilot Study (NCT02295566) | University Hospital Southampton NHS Foundation Trust | 2011-05-01 |
| Microbiota of the Respiratory Flora in Children With Cystic Fibrosis During the First Year of Life (NCT00977158) | Tufts Medical Center | 2011-05-01 |
| Inhaled Xylitol Versus Saline in Stable Subjects With Cystic Fibrosis (NCT01355796) | Joseph Zabner | 2011-05-01 |
| A Novel Assay to Quantify Treatment Response in Cystic Fibrosis (CF) (NCT01626157) | Milene Saavedra | 2011-05-01 |
| A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis (NCT01465529) | AlgiPharma AS | 2011-05-01 |
| Circadian Rhythm In Tobramycin Elimination In Cystic Fibrosis (NCT01207245) | University of Nottingham | 2011-05-01 |
| Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic Fibrosis (NCT01347190) | CSL Behring | 2011-04-01 |
| Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency (NCT01327703) | Forest Laboratories | 2011-04-01 |
| Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® /Pulmoaid® in Patients With Cystic Fibrosis (NCT01337219) | Erempharma | 2011-04-01 |
| Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation (NCT01315665) | University Hospitals Cleveland Medical Center | 2011-04-01 |
| Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) (NCT01349192) | University of North Carolina, Chapel Hill | 2011-04-01 |
| Development of Diabetes in Adults With Cystic Fibrosis (CF) (NCT03644199) | Liverpool Heart and Chest Hospital NHS Foundation Trust | 2011-03-30 |
| Social Cognition in Children Treated for a Brain Tumour (NCT01599052) | University Medical Center Groningen | 2011-03-01 |
| Assess Increased Mortality Risk With Each Year of Delayed Tobramycin Solution (TIS) Initiation, and Effect of TIS on Mortality Across Study Centers (NCT01460849) | Novartis Pharmaceuticals | 2011-03-01 |
| Supplementation of Oral Reduced Glutathione in Pediatric Cystic Fibrosis Patients (NCT02029521) | Clark Bishop | 2011-03-01 |
| A Comparator Study Evaluating Microbiological Resistance and Effects of Alternating Inhaled Antibiotic Therapies (NCT01319253) | Indiana University | 2011-03-01 |
| The Infective Pulmonary Exacerbations in Cystic Fibrosis - an Ecological Perspective (NCT01306279) | Imperial College London | 2011-02-01 |
| Study of Yoga as a Therapy for Cystic Fibrosis (CF) Patients (NCT01325766) | Seattle Children's Hospital | 2011-02-01 |
| Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation (NCT01262352) | Vertex Pharmaceuticals Incorporated | 2011-01-01 |
| Effect of Topical and Systemic Decolonization of Staphylococcus Aureus (SA) in Pediatric Cystic Fibrosis (CF) Patients (NCT01229553) | State University of New York - Upstate Medical University | 2011-01-01 |
| Exocrine Pancreatic Function Testing in Cystic Fibrosis (NCT01446861) | Haukeland University Hospital | 2011-01-01 |
| Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients (NCT01270347) | Amgen | 2011-01-01 |
| Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls (NCT01331980) | University of Arkansas | 2011-01-01 |
| Pharmacokinetics of Linezolid in Children With Cystic Fibrosis (NCT00625703) | University of Texas Southwestern Medical Center | 2010-12-01 |
| Cystic Fibrosis - Insulin Deficiency, Early Action (NCT01100892) | Sydney Children's Hospitals Network | 2010-12-01 |
| The Role of Respiratory Viruses in Exacerbations of Cystic Fibrosis in Adults (NCT01238081) | Manchester University NHS Foundation Trust | 2010-12-01 |
| Duplication in CHIT1 Gene and the Risk for Aspergillus Lung Disease in CF Patients (NCT01572870) | Rambam Health Care Campus | 2010-12-01 |
| Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability (NCT01241942) | University of North Carolina, Chapel Hill | 2010-12-01 |
| Development Of An Innovative Panel of Methods To Measure Intestinal Macronutrient Digestion, Absorption, and Function (NCT01494909) | Texas A&M University | 2010-11-15 |
| MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis (NCT01180634) | Amgen | 2010-11-04 |
| Probiotics in Cystic Fibrosis (NCT01956916) | Federico II University | 2010-10-01 |
| Small Intestinal Function in Patients With Cystic Fibrosis (NCT01468428) | University of Aarhus | 2010-10-01 |
| Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis (NCT01201434) | Sheba Medical Center | 2010-10-01 |
| Study of the Effect of VX-770 on Hyperpolarized Helium-3 Magnetic Resonance Imaging in Subjects With Cystic Fibrosis and the G551D Mutation (NCT01161537) | Vertex Pharmaceuticals Incorporated | 2010-10-01 |
| Study of VX-809 Alone and in Combination With VX-770 in Cystic Fibrosis (CF) Patients Homozygous or Heterozygous for the F508del-CFTR Mutation (NCT01225211) | Vertex Pharmaceuticals Incorporated | 2010-10-01 |
| Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects (NCT01216046) | Vertex Pharmaceuticals Incorporated | 2010-10-01 |
| Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients (NCT01329172) | University Hospital, Lille | 2010-09-20 |
| Absorptive Clearance After Inhaled Osmotics in Cystic Fibrosis (NCT01223183) | University of Pittsburgh | 2010-09-01 |
| Evaluation of Ciprofloxacin for Inhalation to Cystic Fibrosis Patients With P. Aeruginosa (NCT01090908) | Aradigm Corporation | 2010-09-01 |
| Tiotropium Bromide in Cystic Fibrosis (NCT01179347) | Boehringer Ingelheim | 2010-09-01 |
| Sitagliptin in Cystic Fibrosis-Related Diabetes (NCT01257464) | University of British Columbia | 2010-09-01 |
| Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis (NCT03652090) | Institut National de la Santé Et de la Recherche Médicale, France | 2010-09-01 |
| CFfone: A Cell Phone Support Program for Adolescents With Cystic Fibrosis (NCT01183286) | Dawkins Productions, Inc. | 2010-09-01 |
| Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis (NCT01222273) | University of Pittsburgh | 2010-09-01 |
| Extension Study of Ataluren (PTC124) in Cystic Fibrosis (NCT01140451) | PTC Therapeutics | 2010-08-12 |
| A Safety and Tolerability Study of Denufosol in 2-4 Year Olds (NCT01181622) | Merck Sharp & Dohme LLC | 2010-08-01 |
| Phase II Study of Digitoxin to Treat Cystic Fibrosis (NCT00782288) | National Jewish Health | 2010-08-01 |
| Study of Individualized Physiotherapy for Airway Clearance in Cystic Fibrosis. (NCT01266473) | Oslo University Hospital | 2010-08-01 |
| PR-018: An Open-Label, Safety Extension of Study PR-011 (NCT01131507) | Forest Laboratories | 2010-07-01 |
| Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer (NCT01116089) | Chiesi Farmaceutici S.p.A. | 2010-07-01 |
| Rollover Study of VX-770 in Cystic Fibrosis Subjects (NCT01117012) | Vertex Pharmaceuticals Incorporated | 2010-07-01 |
| The Natural History of Small Airways Physiology in Diseased and Healthy States (NCT00677560) | Imperial College London | 2010-06-22 |
| Cystic Fibrosis (CF) Exacerbation and Insulin Treatment (NCT01149005) | Hadassah Medical Organization | 2010-06-01 |
| A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age (NCT01100606) | Forest Laboratories | 2010-06-01 |
| Inhaled Glutathione (GSH) Versus Placebo in Cystic Fibrosis (NCT01450267) | Serafino A. Marsico | 2010-06-01 |
| Study of Docosahexanoic Acid in Patients With Cystic Fibrosis (CF) (NCT02690857) | Hospices Civils de Lyon | 2010-05-01 |
| Prevention of Cystic Fibrosis Diabetes (NCT00967798) | Emory University | 2010-05-01 |
| Statins To Treat Adult Cystic Fibrosis (NCT01092572) | University of British Columbia | 2010-05-01 |
| Ghrelin in Cystic Fibrosis (NCT00763477) | Papworth Hospital NHS Foundation Trust | 2010-04-01 |
| A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients (NCT01093521) | University of Washington | 2010-04-01 |
| Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis (NCT01460836) | Novartis Pharmaceuticals | 2010-04-01 |
| Prospective Intervention Study on Vitamin D in Patients With Cystic Fibrosis (NCT01321905) | Karolinska Institutet | 2010-04-01 |
| Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF) (NCT01180842) | Children's Hospitals and Clinics of Minnesota | 2010-03-01 |
| Sino-nasal Inhalation of Sodium Chloride 6,0% in Patients With Cystic Fibrosis and Chronic Rhinosinusitis (NCT01086839) | University of Jena | 2010-03-01 |
| A Prospective, Multicenter, Collaborative Study to Determine the Prevalence of Nontuberculous Mycobacteria (NTM) in Pediatric Patients With Cystic Fibrosis in Florida (NCT02198079) | University of Miami | 2010-03-01 |
| Changes in Lung Function Based on Differences in Spirometry Equipment Used in Children With Cystic Fibrosis (NCT01343524) | State University of New York - Upstate Medical University | 2010-03-01 |
| Pharmacokinetic Bioequivalence Study of Nebcinal® 150mg/3ml Administered by Aeroneb® Idehaler® Versus Tobi® 300mg/5ml Administered by Pari LC Plus® (NCT01288170) | Erempharma | 2010-02-01 |
| Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770 (NCT01060566) | Vertex Pharmaceuticals Incorporated | 2010-02-01 |
| Standardisation of Measurements in Exhaled Breath and Exhaled Breath Condensate. (NCT00983671) | Maastricht University Medical Center | 2010-02-01 |
| Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection (NCT01059565) | Gilead Sciences | 2010-02-01 |
| Glutamine Supplementation in Cystic Fibrosis (NCT01051999) | Emory University | 2010-02-01 |
| High Frequency Chest Wall Oscillation and Cystic Fibrosis (NCT01057524) | Imperial College London | 2010-02-01 |
| High Volumes of Hypertonic Saline and Chest Physiotherapy in CF Patients (NCT01943890) | Haukeland University Hospital | 2010-02-01 |
| Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic Fibrosis (NCT01072721) | Assistance Publique - Hôpitaux de Paris | 2010-01-19 |
| Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis (NCT01144507) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-01-12 |
| Inflammatory and Microbiologic Markers in Sputum: Comparing Cystic Fibrosis With Primary Ciliary Dyskinesia (NCT01155115) | The Hospital for Sick Children | 2010-01-01 |
| Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis (NCT01044719) | Imperial College London | 2010-01-01 |
| The Effect of Inhaled N-Acetylcysteine Compared to Normal Saline on Sputum Rheology and Lung Function (NCT00996424) | University Hospital, Ghent | 2010-01-01 |
| Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients (NCT01658449) | Ospedale Civile Ca' Foncello | 2009-12-01 |
| Improving Adherence and Clinical Outcome in Cystic Fibrosis (CF) Patients (NCT01025258) | Sheba Medical Center | 2009-12-01 |
| Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis (NCT00812045) | AstraZeneca | 2009-12-01 |
| A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF) (NCT01025713) | Gilead Sciences | 2009-12-01 |